Publications by authors named "Dondapati Venkata Vamshi Krishna"
Article Synopsis
- The COVID-19 pandemic posed significant health challenges, prompting a study on the potential benefits of surfactant therapy for patients with acute respiratory distress syndrome (ARDS) caused by the virus.
- Researchers conducted a detailed search for relevant studies, analyzing data from various databases to assess the impact of surfactant therapy on mortality and hospitalization lengths in COVID-19 patients with ARDS.
- The study, including four studies with 126 patients, indicated that surfactant therapy may lead to lower hospitalization times and mortality rates, although the mortality difference wasn't statistically significant, highlighting the need for further research with larger sample sizes to validate these findings.
Article Synopsis
- * A thorough literature review yielded 10 case reports indicating that this condition can develop approximately 16.2 days post-vaccination, mostly in younger males after the second dose.
- * Though vaccination-related vasculitis is uncommon, it is a noted potential complication, highlighting the need for more understanding and treatment guidelines.
Despite advances in the management of type 2 diabetes mellitus (T2DM), one-third of patients with diabetes do not achieve the desired glycemic goal. Considering this inadequacy, many agents that activate glucokinase have been investigated over the last two decades but were withdrawn before submission for marketing permission. Dorzagliatin is the first glucokinase activator that has been granted approval for T2DM, only in China.
View Article and Find Full Text PDFIsolated cases of subacute thyroiditis exist in the early period of COVID-19 vaccination, largely after mRNA vaccines. Here we report late onset thyroid disturbances and persistent health issues in patients of thyroid disorders after COVID-19 vaccination. Seventy-five patients with post COVID-19 vaccination thyroid disturbances were identified.
View Article and Find Full Text PDF